Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR

Leukemia Research

Volumn 27, Issue 7, 2003, Pages 575-582

  Curry, John D ^a   Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Childhood; Lymphocytic leukemia; Real time PCR; SIL TAL1; Translocation

Indexed keywords

RAG2 PROTEIN; RNA;

ADULT; ARTICLE; CELL LINE; CONTROLLED STUDY; FUSION GENE; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MOLECULAR CLONING; NEWBORN; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA TRANSCRIPTION; SIL GENE; T CELL LEUKEMIA; TAL1 GENE;

ADULT; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; CHROMOSOME BREAKAGE; CHROMOSOMES, HUMAN, PAIR 1; DNA NUCLEOTIDYLTRANSFERASES; DNA PRIMERS; DNA-BINDING PROTEINS; GENE DELETION; GENE DOSAGE; HELIX-LOOP-HELIX MOTIFS; HUMANS; INFANT, NEWBORN; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTES; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PLASMIDS; PROTEINS; PROTO-ONCOGENE PROTEINS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; VDJ RECOMBINASES;

EID: 0037411253     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00260-6     Document Type: Article

References (27)

1. Aplan P.D., Nakahara K., Orkin S.H., Kirsch I.R. The SCL gene product: a positive regulator of erythroid differentiation. EMBO J. 11:1992;4073-4081.
2. Visvader J., Begley C.G., Adams J.M. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. Oncogene. 6:1991;187-194.
3. Cross M.A., Heyworth C.M., Murrell A.M., Bockamp E.O., Dexter T.M., Green A.R. Expression of lineage restricted transcription factors precedes lineage-specific differentiation in a multipotent hemopoietic progenitor cell line. Oncogene. 9:1994;3013-3016.
4. Chen Q., Cheng J.T., Tasi L.H., Schneider N., Buchanan G., Carroll A.et al. The tal gene undergoes chromosome translocation in T-cell leukemia and potentially encodes a helix-loop-helix protein. EMBO J. 9:1990;415-424.
5. Aplan P.D., Lombardi D.P., Ginsberg A.M., Cossman J., Bertness V.L., Kirsch I.R. Disruption of the human SCL locus by "illegitimate" V(D)J recombinase activity. Science. 250:1990;1426-1429.
6. Brown L., Cheng J.T., Chen Q., Siciliano M.J., Crist W., Buchanan G.et al. Site-specific recombination of the tal-1 gene is a common occurrence in human T-cell leukemia. EMBO J. 9:1990;3343-3351.
7. Janssen J.W., Ludwig W.D., Sterry W., Bartram C.R. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia. 7:1993;1204-1210.
8. Bash R.O., Hall S., Timmons C.F., Crist W.M., Amylon M., Smith R.G.et al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood. 86:1995;666-676.
9. Delabesse E., Bernard M., Landman-Parker J., Davi F., Leboeuf D., Varet B.et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br. J. Haematol. 99:1997;901-907.
10. Lipkowitz S., Garry V.F., Kirsch I.R. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc. Natl. Acad. Sci. U.S.A. 89:1992;5301-5305.
11. Garry V.F., Tarone R.E., Kirsch I.R., Abdallah J.M., Lombardi D.P., Long L.K.et al. Biomarker correlations of urinary 2,4-D levels in foresters: genomic instability and endocrine disruption. Environ. Health Perspect. 109:2001;495-500.
12. Liu Y., Hernandez A.M., Shibata D., Cortopassi G.A. BCL-2 translocation frequency rises with age in humans. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8910-8914.
13. Limpens J., Stad R., Vos C., de Vlaam C., de Jong D., van Ommen G.J.et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood. 85:1995;2528-2536.
14. Yasukawa M., Bando S., Dolken G., Sada E., Yakushijin Y., Fujita S.et al. Low frequency of BCL-2/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood. 98:2001;486-488.
15. Uckun F.M., Herman-Hatten K., Crotty M.L., Sensel M.G., Sather H.N., Tuel-Ahlgren L.et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood. 92:1998;810-821.
16. Trka J., Zuna J., Hrusak O., Michalova K., Muzikova K., Kalinova M.et al. No evidence for MLL-AF4 expression in normal cord blood samples. Blood. 93:1999;1106-1107. [discussion, p. 1108-1110].
17. Kim-Rouille M.H., MacGregor A., Wiedemann L.M., Greaves M.F., Navarrete C. MLL-AF4 gene fusions in normal newborns. Blood. 93:1999;1107-1108.
18. Biernaux C., Loos M., Sels A., Huez G., Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood. 86:1995;3118-3122.
19. Chen X., Pan Q., Stow P., Behm F.G., Goorha R., Pui C.H.et al. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL1 deletion using a standardized real-time PCR assay. Leukemia. 15:2001;166-170.
20. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G.et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 13:1999;1901-1928.
21. Pallisgaard N., Clausen N., Schroder H., Hokland P. Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL-AML1 fusion transcript. Genes Chromosomes Cancer. 26:1999;355-365.
22. Curry J.D., McHale C., Smith M.T. Low efficiency of the Moloney murine leukemia virus reverse transcriptase during reverse transcription of rare t(8;21) fusion gene transcripts. Biotechniques. 32(4):2002;768-775.
23. Curry J.D., McHale C., Smith M.T. Factors influencing real-time RT-PCR results: application of real-time RT-PCR for the detection of leukemia translocations. Mol. Biol. Today. 3:2002;79-84.
24. Fuscoe J.C., Zimmerman L.J., Lippert M.J., Nicklas J.A., O'Neill J.P., Albertini R.J. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T lymphocytes. Cancer Res. 51:1991;6001-6005.
25. Fuscoe J.C., Zimmerman L.J., Harrington-Brock K., Burnette L., Moore M.M., Nicklas J.A.et al. V(D)J recombinase-mediated deletion of the hprt gene in T lymphocytes from adult humans. Mutat. Res. 283:1992;13-20.
26. Finette B.A., Poseno T., Albertini R.J. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res. 56:1996;1405-1412.
27. Wang Q.F., Lauring J., Schlissel M.S. The c-myb binds to a sequence in the proximal region of the RAG2 promoter and is essential for promoter activity in T-lineage cells. Mol. Cell. Biol. 20:2000;9203-9211.